1. Successful treatment of disseminated Verruconis gallopava infection in a heart transplant recipient: A case report.
- Author
-
Martin M, Hobbs ALV, and Baird M
- Subjects
- Anidulafungin, Antifungal Agents therapeutic use, Humans, Male, Middle Aged, Ascomycota, Heart Transplantation adverse effects, Mycoses etiology, Mycoses microbiology
- Abstract
Purpose: To describe a case of disseminated Verruconis gallopava infection in a cardiac transplant recipient that was successfully treated with oral posaconazole and intravenous anidulafungin., Summary: A 51-year-old male initially presented with pulmonary manifestations, but subsequently developed cutaneous lesions, fungemia, osteomyelitis of the hip requiring excision, and eventually brain abscesses over the course of 3 months. The patient was successfully treated with various antifungal agents throughout his treatment course and was eventually discharged on oral posaconazole and intravenous anidulafungin. He remained on oral posaconazole suppressive therapy and had had no recurrence of fungal infection after 31 months of follow-up., Conclusion: On the basis of this case report, intravenous anidulafungin and chronic suppressive therapy with oral posaconazole can successfully treat disseminated V. gallopava infections., (© American Society of Health-System Pharmacists 2022. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF